Earlier than the month is over, Pennsylvania residents affected by anxiousness issues and Tourette’s syndrome will be capable to entry authorized cannabis.
On Thursday, Pennsylvania’s Division of Well being officers added anxiousness dysfunction to the state’s checklist of qualifying circumstances for medical marijuana, probably opening entry to greater than one million residents.
In keeping with the Philadelphia Inquirer, the DOH Medical Marijuana Advisory Board confirmed anxiousness because the state’s 22nd qualifying situation this week after a evaluate by Pennsylvania Well being Secretary Rachel Levine. Along with anxiousness dysfunction, Levine and the DOH authorized Tourette’s syndrome as this system’s 23rd qualifying situation.
“I didn’t take this choice calmly,” Levine stated in a press release. “For each circumstances, medical marijuana shouldn’t be first-line therapy and shouldn’t change conventional therapies, however needs to be used along side them, when advisable by a doctor.”
Pennsylvania’s medical marijuana program started retail dispensary gross sales in early 2018, and has since registered greater than 137,000 sufferers. With the addition of hysteria and Tourette’s to the checklist of qualifying circumstances, although, that quantity may rapidly develop at an exponential price.
In keeping with statistics from the Anxiousness and Melancholy Affiliation of America dug up by Inquirer reporter Sam Wooden, some 18% of all People endure from anxiousness dysfunction, probably translating to greater than 1.7 million Pennsylvanians.
Whereas a variety of states approve particular types of anxiousness dysfunction like PTSD as qualifying circumstances for medical marijuana, solely two different states — New Jersey and Ohio — think about basic anxiousness dysfunction purpose sufficient to entry authorized weed. Coincidentally, Pennsylvania neighbors each of these states.
Along with the practically million-plus Keystone State residents that might quickly qualify for medical cannabis, greater than 200,000 People endure from Tourette’s syndrome, pushing this system’s scope even additional. The brand new program expansions will go into impact subsequent week, on July 21st.
Comply with Zach Harris on Twitter